Results Recombinant human erythropoietin extenuates cisplatin-induced neuropathy Repetitive applications of cisplatin (2 mg/kg/week) for 8 weeks resulted in a highly significant decrease of sensory nerve conduction velocity (SNCV) by ~40% compared to control (Figure 1 ).
← all excerpts
Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.
1
—
—